Study of a DNA Immunotherapy to Treat Melanoma

Clinical trial NCT01138410 · TERMINATED

Trial details

NCT number: NCT01138410
Sponsor: Scancell Ltd
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2010-05-01
Primary completion: 2017-07-07
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.